ALIBREX
Live / Registered — Registered (as of 22 Sept 2020)
What this means for you
Registered since 22 Sept 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88299485
- Registration number
- 6159041
- Mark type
- Stylized text
- Filed
- 13 Feb 2019
- Published for opposition
- 10 Dec 2019
- Registered
- 22 Sept 2020
- Attorney of record
- James K. Stronski
Goods and services
- Class 005 — Pharmaceuticals: Medical diagnostic assays for testing of bodily fluids, namely, assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; Medical diagnostic test media in the form of reagents used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; medical diagnostic kits comprised of medical diagnostic reagents and assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy
- Class 042 — Scientific and technological services: Medical and scientific research in the field of medical diagnostic assays and clinical testing services for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy
- Class 044 — Medical, beauty and agricultural services: Medical testing for diagnostic or treatment purposes, namely, for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy
Owner
- ONECELL DIAGNOSTICS, INC., CUPERTINO, CA, US
- Cadex Genomics, Corp., Redwood City, CA, US
- Cadex Genomics, Corp., Redwood City, CA, US
- Cadex Genomics, Corp., Redwood City, CA, US
Prosecution history
- 22 Sept 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 02 Apr 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 22 Sept 2020 — REGISTERED-PRINCIPAL REGISTER
- 18 Aug 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Aug 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Aug 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Aug 2020 — USE AMENDMENT FILED
- 13 Aug 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Aug 2020 — TEAS STATEMENT OF USE RECEIVED
- 04 Feb 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Dec 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Dec 2019 — PUBLISHED FOR OPPOSITION
- 20 Nov 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Nov 2019 — ASSIGNED TO LIE
- 28 Oct 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER